Dr. Juan Rendon, MD, PhD

Dr. Rendon practices at The Aesthetic Institute in Torrance, California.

Dr. Rendon's NPI, 1720492812, was assigned on June 17, 2014. Dr. Rendon graduated from Loyola University Chicago Stritch School of Medicine in 2014. Dr. Rendon holds California license A172824.

Dr. Rendon's primary practice is The Aesthetic Institute, at 3640 Lomita Blvd Ste 302, Torrance, CA 90505. The practice phone is (310) 784-0644.

Dr. Rendon's primary practice is The Aesthetic Institute in Torrance, California. Dr. Rendon is also affiliated with Torrance Memorial Medical Center. The medical group on file is South Bay Plastic Surgeons. Dmand AI also links Dr. Rendon to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Rendon's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rendon practices, 5 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Rendon's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Rendon is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Rendon's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists breast surgery and removal of damaged skin or skin graft among the conditions Dr. Rendon treats.

CMS data shows 17 Medicare services from Dr. Rendon across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $2,852 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Rendon in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rendon's median patient age at 62, with 82% women.

In 2024, Dr. Rendon wrote 109 Medicare Part D claims for 36 patients. 99% of them were for generic drugs. CMS names the drug for 76 of them, across 4 drugs with 11 or more claims each, at $195 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

CMS counts 18 procedures of mastectomy by Dr. Rendon, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Rendon, published from 2012 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Burns, Disease Models, Animal and Alcoholic Intoxication. Dr. Rendon has published most often in Plast Reconstr Surg Glob Open. Dr. Rendon's most frequent co-authors are Roman J. Skoracki, MD, Michelle Lee Humeidan, MD and Casey Kraft, MD.

CMS Open Payments shows 108 general payments to Dr. Rendon from 27 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 57% of the total. Allergan Inc. paid the most, $2,239.

Dr. Rendon graduated from Loyola University Chicago Stritch School of Medicine in 2014.

Dr. Rendon is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.